Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 8/20 | 0.83 |
| ▸ | MEN1 | O00255 | 7/20 | 0.83 |
| ▸ | KCNK3 | O14649 | 6/20 | 0.79 |
| ▸ | KCNK9 | Q9NPC2 | 4/20 | 0.79 |
| ▸ | RAB9A | P51151 | 6/20 | 0.73 |
| ▸ | NPC1 | O15118 | 5/20 | 0.73 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.73 |
| ▸ | TP53 | P04637 | 2/20 | 0.73 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.69 |
| ▸ | MAPT | P10636 | 3/20 | 0.69 |
| ▸ | LMNA | P02545 | 2/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.66 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22589002 | 0.92 | SIRT1 (0.79) | KMT2AMEN1KCNK3KCNK9RAB9A | |
| SCHEMBL29800565 | 0.91 | MEN1 (0.93) | KMT2AMEN1KCNK3KCNK9RAB9A | |
| SCHEMBL11675529 | 0.91 | MEN1 (1.00) | KMT2AMEN1KCNK3KCNK9RAB9A | |
| SCHEMBL6793906 | 0.91 | MEN1 (0.93) | KMT2AMEN1KCNK3KCNK9RAB9A | |
| SCHEMBL28218534 | 0.91 | KMT2A (0.69) | KMT2AMEN1KCNK3KCNK9RAB9A | |
| SCHEMBL2063559 | 0.89 | KMT2A (0.77) | KMT2AMEN1KCNK3KCNK9RAB9A | |
| SCHEMBL21707396 | 0.89 | MEN1 (0.89) | KMT2AMEN1KCNK3KCNK9RAB9A | |
| SCHEMBL3656361 | 0.89 | NPC1 (0.78) | KMT2AMEN1KCNK3KCNK9RAB9A | |
| SCHEMBL2298254 | 0.88 | KCNK3 (1.00) | KMT2AMEN1KCNK3KCNK9RAB9A | |
| N-Phenylbenzamide SCHEMBL27671345 | 0.86 | POLB (0.71) | KMT2AMEN1KCNK3KCNK9RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-52116432-A | — | — | None | — | — | JP | disclosed |
| US-20260001999-A1 | HYDROPHILIC OIL REPELLENT POLYMER | SUMITOMO CHEMICAL CO (JP) | 2026-01-01 | — | — | US | disclosed |
| EP-4578895-A1 | POLYMER, RESIN COMPOSITION, MOLDED BODY, AND POLYMER PRODUCTION METHOD | Sumitomo Chemical Company, Limited (JP) | 2025-07-02 | — | — | EP | disclosed |
| EP-4578894-A1 | HYDROPHILIC OIL REPELLENT POLYMER | Sumitomo Chemical Company, Limited (JP) | 2025-07-02 | — | — | EP | disclosed |
| CN-119604562-A | Hydrophilic oil-repellent polymer | 住友化学株式会社 | 2025-03-11 | — | — | CN | disclosed |
| WO-2024043326-A1 | HYDROPHILIC OIL REPELLENT POLYMER | 住友化学株式会社 | 2024-02-29 | — | — | WO | disclosed |
| WO-2024043327-A1 | POLYMER, RESIN COMPOSITION, MOLDED BODY, AND POLYMER PRODUCTION METHOD | 住友化学株式会社 | 2024-02-29 | — | — | WO | disclosed |
| US-20230129965-A1 | HYDROPHILIC AND OLEOPHOBIC POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-04-27 | — | — | US | disclosed |
| EP-4130057-A1 | HYDROPHILIC OIL REPELLENT POLYMER | Sumitomo Chemical Company, Limited (JP) | 2023-02-08 | — | — | EP | disclosed |
| WO-2022255400-A1 | CLEANER FOR INDOOR WATER USE SITES | 住友化学株式会社 | 2022-12-08 | — | — | WO | disclosed |
| US-20160031797-A1 | ESTROGEN RECEPTOR LIGANDS AND METHODS OF USE THEREOF | GTX, INC. | 2016-02-04 | — | — | US | disclosed |
| WO-2014195507-A1 | 3-CARBOXY SUBSTITUTED COUMARIN DERIVATIVES WITH A POTENTIAL UTILITY FOR THE TREATMENT OF CANCER DISEASES | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2014-12-11 | — | — | WO | disclosed |
| US-8293715-B2 | 10a-Azalide compound crosslinked at 10a- and 12-positions | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2012-10-23 | — | — | US | disclosed |
| US-20110237784-A1 | 10A-AZALIDE COMPOUND CROSSLINKED AT 10A- AND 12-POSITIONS | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2011-09-29 | — | — | US | disclosed |
| EP-2177526-A1 | 10A-AZALIDE COMPOUND CROSSLINKED AT POSITION-10A AND POSITION-12 | Taisho Pharmaceutical Co. Ltd. (JP) | 2010-04-21 | — | — | EP | disclosed |
| US-20070060607-A1 | 4-amino-thieno[3,2-c] pyridine-7-carboxylic acid derivatives | BARTKOVITZ DAVID J | 2007-03-15 | — | — | US | disclosed |
| EP-1633715-A1 | 2-(6-AMINO-PYRIDIN-3-YL)-2-HYDROXYETHYLAMINE DERIVATIVES AS BETA 2-ADRENOCEPTORS AGONISTS | Pfizer Limited (GB) | 2006-03-15 | — | — | EP | disclosed |
| WO-2004108676-A1 | 2-(6-AMINO-PYRIDIN-3-YL)-2-HYDROXYETHYLAMINE DERIVATIVES AS BETA 2-ADRENOCEPTORS AGONISTS | PFIZER LIMITED (GB) | 2004-12-16 | — | — | WO | disclosed |
| US-5372917-A | Excellent color forming property, storage stability and recorded image preservability; pyrazolone derivatives | KANZAKI PAPER MANUFACTURING CO., LTD. (JP) | 1994-12-13 | — | — | US | disclosed |
| JP-S52116432-A | PREPARATION OF 3-ALKOXYBENZANILIDES | KUMIAI CHEM IND CO LTD | 1977-09-29 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110237784-A1 | 10A-AZALIDE COMPOUND CROSSLINKED AT 10A- AND 12-POSITIONS | DCLRE1A, AZI2, CHD9 | KMT2A 568/4885MEN1 3118/4885KCNK3 3756/4885 |
| US-20160031797-A1 | ESTROGEN RECEPTOR LIGANDS AND METHODS OF USE THEREOF | ESRRB, ESRRA, ESR2 | KMT2A 2272/4885MEN1 3937/4885KCNK3 3604/4885 |
| US-20070060607-A1 | 4-amino-thieno[3,2-c] pyridine-7-carboxylic acid derivatives | BRAF, RAF1, MAP3K7 | KMT2A 1605/4885MEN1 1791/4885KCNK3 2318/4885 |
| US-20260001999-A1 | HYDROPHILIC OIL REPELLENT POLYMER | CCR1, H1-3, CCR3 | KMT2A 1993/4885MEN1 1349/4885KCNK3 2814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.